Institution Directory

Clinical trials at Yale

Sites in New Haven, CT

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 5:06 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1245

Shown on this page

Current sort

Live official records

Conditions: Health Technology
Interventions: Email, Text, Patient Portal Message; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 5,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 4
States / cities: New Haven, Connecticut

Conditions: Rheumatic Diseases, Adult Onset Still Disease, Ankylosing Spondylitis, Psoriatic Arthritis, Reactive Arthritis, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Behcet Disease, Dermatomyositis, Polymyositis, Giant Cell Arteritis, Lyme Disease, Mixed Connective Tissue Disease, Polymyalgia Rheumatica, Rheumatoid Arthritis, Sarcoidosis, Systemic Sclerosis, Scleroderma, Sjogren's Syndrome, Undifferentiated Connective Tissue Diseases
Interventions: Not listed
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Bronchiolitis Acute Viral
Interventions: Educational Outreach, Audit & Feedback (unit level), Audit & Feedback (real time, individual-level), Clinical Pathway Integrated into Electronic Health Record; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Months and older
Enrollment: 9,265 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 50
States / cities: Birmingham, Alabama • Davis, California • Encinitas, California + 42 more

Conditions: Alzheimer's Disease
Interventions: E2814, Lecanemab, Placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 18
States / cities: Phoenix, Arizona • New Haven, Connecticut • Bradenton, Florida + 15 more

Conditions: Breast Cancer
Interventions: Gedatolisib, Palbociclib, Fulvestrant, Alpelisib; Drug
Lead sponsor: Celcuity Inc; Industry
Eligibility: 18 Years and older
Enrollment: 701 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 71
States / cities: Birmingham, Alabama • Goodyear, Arizona • Jonesboro, Arkansas + 62 more

Conditions: Melanoma
Interventions: cemiplimab, Fixed Dose Combination (FDC) cemiplimab+fianlimab, Placebo; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 28
States / cities: La Jolla, California • Los Angeles, California • Newport Beach, California + 22 more

Conditions: Early Breast Cancer
Interventions: Endocrine therapy interruption; Other
Lead sponsor: ETOP IBCSG Partners Foundation; Network
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 518 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 103
States / cities: Los Angeles, California • Palo Alto, California • San Diego, California + 77 more

Conditions: Respiratory Syncytial Virus Infections
Interventions: AZM Group, Control Group; Drug · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 3 Days to 2 Years
Enrollment: 370 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 15
States / cities: Birmingham, Alabama • San Francisco, California • New Haven, Connecticut + 12 more

Conditions: Autism Spectrum Disorder
Interventions: Transcranial Magnetic Stimulation (TMS); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Laryngeal Dystonia
Interventions: Starstim system; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Type 1 Diabetes (T1D), Diabetes Secondary to Pancreatitis
Interventions: Mindfulness app; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Cervical Preparation Prior to Dilation and Evacuation
Interventions: Cervical Ripening Double Balloon (CRDB) Catheter, Osmotic Dilators; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: New Haven, Connecticut

About this Yale institution page

What this page lists: ClinicalTrials.gov records that list Yale in New Haven, CT as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Yale

Filter and sort this campus

Live official records

MyChart Proxy Outreach to Parents (MyPOP)

Rheumatology Patient Registry and Biorepository

Eliminating Monitor Overuse Trial (EMO Trial)

A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children

Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

tDCS for Laryngeal Dystonia

Digital Mindfulness for Young Adults With Type 1 Diabetes

RCT of Cervical Ripening Double Ballon Catheter Prior to Dilation and Evacuation.

About this Yale institution page